Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vijaya L et al. – Betaxolol ophthalmic suspension 0.25%, TGFS 0.25%, and TGFS 0.5% were well tolerated. Despite low responder rates, all 3 treatments produced statistically significant mean reductions in IOP in pediatric glaucoma subjects.


Today in Clinical Pharmacology...keeping you current

Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09

Today in Glaucoma...keeping you current

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Natural History of Open-Angle Glaucoma
Ophthalmology, 10/28/09

Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma
Clinical Ophthalmology, 11/23/09

Today in Pediatric Ophthalmology...keeping you current

Ocular manifestations of the Johanson-Blizzard syndrome
Journal of American Association for Pediatric Ophthalmology and Strabismus , 11/03/09

Retinopathy of Prematurity
NeoReviews, 11/04/09

Trilateral retinoblastoma: Potentially curable with intensive chemotherapy
Pediatric Blood & Cancer, 11/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address